Wright Medical Group N.V. (WMGI)
(Delayed Data from NSDQ)
$29.93 USD
+0.29 (0.98%)
Updated May 3, 2019 04:00 PM ET
After-Market: $29.93 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$29.93 USD
+0.29 (0.98%)
Updated May 3, 2019 04:00 PM ET
After-Market: $29.93 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Wright Medical Group (WMGI) to Report Q1 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Wright Medical (WMGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wright Medical (WMGI) Down 7.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Wright Medical (WMGI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain Wright Medical Stock For Now
by Zacks Equity Research
Wright Medical (WMGI) is gaining traction from strong international presence and robust product portfolio. However, adverse forex continues to raise concerns.
Company News For Nov 5, 2019
by Zacks Equity Research
Companies In The News Are: WMGI, ENLV, CRNT, UAA
Will Wright Medical Group (WMGI) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Wright Medical (WMGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Ceridian HCM, Palo Alto Networks, Wright Medical and Calix
by Zacks Equity Research
Zacks.com featured highlights include: Ceridian HCM, Palo Alto Networks, Wright Medical and Calix
Here's Why You Should Hold on to Wright Medical (WMGI) Stock
by Zacks Equity Research
Strong international footprint, solid prospects in the global orthopedic space and an enhanced product pipeline bode well for Wright Medical (WMGI). However, adverse forex mars prospects.
4 Toxic Stocks Investors Should Steer Clear Of Right Now
by Zacks Equity Research
Abandoning toxic stocks at the right time is the key to safeguard your portfolio from big losses.
Zacks.com featured highlights include: Camping World, Golden Entertainment, Wright Medical and Exterran
by Zacks Equity Research
Zacks.com featured highlights include: Camping World, Golden Entertainment, Wright Medical and Exterran
4 Toxic Stocks to Dispose of or Sell Short for Solid Gains
by Zacks Equity Research
Generally overhyped toxic stocks are susceptible to outside shocks. Moreover, these stocks are loaded with a high level of debt.
Here's Why You Should Retain Wright Medical Stock For Now
by Zacks Equity Research
Wright Medical (WMGI) continues to benefit from strong international sales, new product launches and solid prospects in the global Orthopedic space. However, forex remains a woe.
Wright Medical (WMGI) Earnings Beat in Q2, Guidance Slashed
by Zacks Equity Research
Wright Medical (WMGI) gains from Upper and Lower Extremities units in Q2; slashes 2019 view.
Wright Medical Group (WMGI) Q2 Earnings Top Estimates
by Zacks Equity Research
Wright Medical (WMGI) delivered earnings and revenue surprises of 100.00% and -1.62%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Invest in Wright Medical Stock Now
by Zacks Equity Research
Wright Medical (WMGI) continues to benefit from strong international sales, new product launches and solid prospects in the global Orthopedic space.
Wright Medical (WMGI) Up 1.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Wright Medical (WMGI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wright Medical (WMGI) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Wright Medical (WMGI) Q1 results benefit from higher revenues, solid show by Lower as well as Upper Extremities segments and gross margin expansion. However, rising costs remain a woe.
Wright Medical Group (WMGI) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Wright Medical (WMGI) delivered earnings and revenue surprises of 66.67% and 1.57%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Wright Medical Group (WMGI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Wright Medical (WMGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Intuitive Surgical (ISRG) Q1 Earnings, Revenues Lag Estimates
by Zacks Equity Research
Intuitive Surgical's (ISRG) Q1 results outside the United States impress.
Stryker's LIFEPAK CR2 Defibrillator Launch to Boost MedSurg
by Zacks Equity Research
Stryker's (SYK) emergency care department offers a broad range of products and systems.
Here's Why You Should Buy Masimo (MASI) Stock Right Now
by Zacks Equity Research
Masimo (MASI) has been benefitting from developments like the FDA clearance of the Rad-67 Pulse CO-Oximeter.
Why Is Wright Medical (WMGI) Up 1.9% Since Last Earnings Report?
by Zacks Equity Research
Wright Medical (WMGI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain Patterson Companies (PDCO) Stock
by Zacks Equity Research
A diversified product portfolio and strong Dental business prospects provide Patterson Companies (PDCO) a competitive edge in the MedTech space.
Here's Why You Should Invest in Integer Holdings (ITGR) Stock
by Zacks Equity Research
Integer Holdings (ITGR) is likely to gain from the Cardio & Vascular, Neuromodulation and Non-Medical Electrochem markets.
Inogen's Prospects in Europe Solid Amid Trade-Related Tension
by Zacks Equity Research
Inogen's (INGN) business-to-business unit sees strength in Europe.